Speciality: Nephrology
Description:
A warm welcome to all the medical professionals in this interesting session on Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor
Holistic care in chronic kidney disease (CKD) management emphasizes kidney protection alongside overall patient well-being, with SGLT2 inhibitors playing a pivotal role. These drugs not only slow CKD progression but also address comorbidities like heart failure and diabetes, reducing hospitalization risks and enhancing quality of life. Their ability to lower albuminuria and improve glycemic control aligns with a patient-centered approach to renal care.
In optimizing kidney protection, SGLT2 inhibitors exemplify the integration of evidence-based medicine into holistic care strategies. By targeting metabolic and hemodynamic pathways, they provide multifaceted benefits, including cardiovascular risk reduction. This comprehensive approach enables healthcare providers to improve outcomes in CKD patients while addressing interconnected health challenges.
Therefore, get an overall knowledge of Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
Adult overdose deaths on the rise
2.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
3.
To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.
4.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
5.
New study links air pollution with higher rates of head and neck cancer
1.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
2.
Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring
3.
The Importance of Maintaining Normal Calcium Levels in Your Body
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation